L. Thomas

发表

Fetal Distribution of 5α-Reductase 1 and 5α-Reductase 2, and Their Input on Human Prostate Development

H. Klocker, G. Bartsch, C. Sergi, 2007 .

Evidence for atrophy and apoptosis in the prostates of men given finasteride.

R. Rittmaster, G. Rowden, L. Thomas, 1996, The Journal of clinical endocrinology and metabolism.

Androgen-Induced Regrowth in the Castrated Rat Ventral Prostate: Role of 5α-Reductase1.

R. Rittmaster, C. Lazier, L. Thomas, 1999, Endocrinology.

Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.

R. Rittmaster, C. Lazier, L. Thomas, 1999, Endocrinology.

The effects of the dual 5α‐reductase inhibitor dutasteride on localized prostate cancer—results from a 4‐month pre‐radical prostatectomy study

D. Bostwick, M. Gleave, N. Fleshner, 2006, The Prostate.

Insulin‐like growth factor binding protein 5 is associated with involution of the ventral prostate in castrated and finasteride‐treated rats

P. Cohen, R. Rittmaster, C. Lazier, 1998, The Prostate.

The Prostate 69 : 595 ^ 602 ( 2009 ) Overexpressionof 5 a-ReductaseType 1 Increases Sensitivityof ProstateCancerCells to Low Concentrations of Testosterone

C. K. Too, R. Rittmaster, L. Thomas, 2009 .

Effect of Steroid 5α-Reductase Inhibitors on Markers of Tumor Regression and Proliferation in Prostate Cancer

R. Rittmaster, L. Thomas, 2009 .

Levels of 5α-Reductase Type 1 and Type 2 are Increased in Localized High Grade Compared to Low Grade Prostate Cancer

C. K. Too, P. Murphy, R. Rittmaster, 2008 .

The Effects of theDual 5a -Reductase Inhibitor Dutasteride onLocalized ProstateCancer Results

D. Bostwick, M. Gleave, N. Fleshner, 2006 .

The Effects of theDual 5 a-Reductase Inhibitor Dutasteride onLocalized ProstateCancer Results Froma 4-Month Pre-Radical ProstatectomyStudy

D. Bostwick, M. Gleave, N. Fleshner, 2006 .

Differential alterations in 5α‐reductase type 1 and type 2 levels during development and progression of prostate cancer

D. Troyer, R. Gupta, R. Rittmaster, 2005 .

Effect of the dual 5α-reductase inhibitor dutasteride on markers of tumor regression in prostate cancer

M. Gleave, J. Trachtenberg, G. Andriole, 2004 .

Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.

C. K. Too, L. Thomas, S. Koirala, 2014, Molecular endocrinology.

S100A10 Has a Critical Regulatory Function in Mammary Tumor Growth and Metastasis: Insights Using MMTV-PyMT Oncomice and Clinical Patient Sample Analysis

P. Marcato, D. Waisman, P. Marignani, 2020, Cancers.

5alpha-reductase type 1 immunostaining is enhanced in some prostate cancers compared with benign prostatic hyperplasia epithelium.

I. Thompson, D. Troyer, R. Gupta, 2003, The Journal of urology.

S100A10 Has a Critical Regulatory Function in Mammary Tumor Growth and Metastasis: Insights Using MMTV-PyMT Oncomice and Clinical Patient Sample Analysis

P. Marcato, D. Waisman, P. Marignani, 2020, Cancers.

Testosterone and prolactin increase carboxypeptidase‐D and nitric oxide levels to promote survival of prostate cancer cells

C. K. Too, L. Thomas, Timothy J Morehouse, 2012, The Prostate.

Levels of 5alpha-reductase type 1 and type 2 are increased in localized high grade compared to low grade prostate cancer.

C. K. Too, P. Murphy, R. Rittmaster, 2008, The Journal of urology.

CAT‐1‐mediated arginine uptake and regulation of nitric oxide synthases for the survival of human breast cancer cell lines

C. K. Too, S. Abdelmagid, J. Rickard, 2011, Journal of cellular biochemistry.

Prolactin‐ and testosterone‐induced carboxypeptidase‐D correlates with increased nitrotyrosines and Ki67 in prostate cancer

C. K. Too, J. Merrimen, R. Rendon, 2015, The Prostate.

Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.

R. Rittmaster, C. Lazier, G. Rowden, 1995, Endocrinology.

Differential alterations in 5alpha-reductase type 1 and type 2 levels during development and progression of prostate cancer.

D. Troyer, R. Gupta, R. Rittmaster, 2005, The Prostate.

Prostatic involution in men taking finasteride is associated with elevated levels of insulin‐like growth factor‐binding proteins (IGFBPs)‐2, ‐4, and ‐5

P. Cohen, R. Rittmaster, C. Lazier, 2000, The Prostate.

Carboxypeptidase‐D is elevated in prostate cancer and its anti‐apoptotic activity is abolished by combined androgen and prolactin receptor targeting

C. K. Too, V. Goffin, J. Merrimen, 2014, The Prostate.

Carboxypeptidase-DisElevatedinProstateCancerandits Anti-ApoptoticActivityisAbolishedbyCombined AndrogenandProlactinReceptorTargeting

C. K. Too, V. Goffin, J. Merrimen, 2014 .

Dutasteride, theDual 5a^Reductase Inhibitor, InhibitsAndrogenAction andPromotesCell Death inthe LNCaPProstateCancerCell Line

R. Rittmaster, J. Vessey, C. Lazier, 2004 .

Type 1 and Type 2 5α-Reductase Expression in the Development and Progression of Prostate Cancer

D. Tindall, C. K. Too, R. Rittmaster, 2008 .

Dutasteride, the dual 5α–reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line

R. Rittmaster, J. Vessey, C. Lazier, 2004 .

Letters to the Editor/ErrataRE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER

M. Gleave, J. Trachtenberg, G. Andriole, 2005 .

Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.

R. Rittmaster, C. Lazier, L. Thomas, 1996, The Journal of clinical investigation.

The utility of tissue transglutaminase as a marker of apoptosis during treatment and progression of prostate cancer.

D. Bell, R. Rittmaster, K. Carlson, 1999, The Journal of urology.

Prolactin and androgen R1881 induce pro-survival carboxypeptidase-D and EDD E3 ligase in triple-negative and HER2+ breast cancer.

C. K. Too, Tyler M MacDonald, L. Thomas, 2020, American journal of cancer research.

Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro

C. K. Too, L. Thomas, Penelope J Barnes, 2017, Breast Cancer Research and Treatment.

Prolactin-inducible EDD E3 ubiquitin ligase promotes TORC1 signalling, anti-apoptotic protein expression, and drug resistance in breast cancer cells.

P. Marignani, C. K. Too, Tyler M MacDonald, 2019, American journal of cancer research.

Type 1 and type 2 5alpha-reductase expression in the development and progression of prostate cancer.

D. Tindall, C. K. Too, R. Rittmaster, 2008, European urology.

Progestin-inducible EDD E3 ubiquitin ligase binds to α4 phosphoprotein to regulate ubiquitination and degradation of protein phosphatase PP2Ac

C. K. Too, L. Thomas, S. Koirala, 2014, Molecular and Cellular Endocrinology.

Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.

R. Rittmaster, J. Vessey, C. Lazier, 2004, The Prostate.

DifferentialAlterations in 5a -ReductaseType1 andType 2 LevelsDuringDevelopment

D. Troyer, R. Rittmaster, C. Lazier, 2005 .

Androgen-Induced Regrowth in the Castrated Rat Ventral Prostate: Role of 5α-Reductase1.

R. Rittmaster, C. Lazier, L. Thomas, 1999, Endocrinology.